Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan ...

On Wednesday, Biocon stock slipped 0.55 per cent to settle at Rs 364.55 apiece on the BSE.

Shares of companies related to pharmaceuticals sector jumped on Sunday after Finance Minister Nirmala Sitharaman proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S's Ozempic and Wegovy in key markets as patents on the blockbuster weight-loss drugs expire next year. The ...

PITTSBURGH, Dec. 6, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has entered into definitive agreements with Biocon Limited ("Biocon") for the sale of Viatris' equity stake ...

Biocon Ltd on Monday said its wholly owned subsidiary, Biocon Pharma Ltd, has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S ...

Budget 2024 proposes Rs 10,000 crore investment in biopharma. Anthem Biosciences, Biocon stocks jump. Impact on pharma sector ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...

(RTTNews) - Biocon Biologics Ltd (BBL), a unit of Biocon Ltd (BIOCON), Thursday said that the U.S. Food and Drug Administration (FDA) has approved Jobevne, a biosimilar to Bevacizumab. Bevacizumab, ...

(RTTNews) - Biocon Biologics, a subsidiary of Biocon Ltd, announced the FDA has approved the company's first-to-file application for Yesafili, an interchangeable biosimilar aflibercept. YESAFILI is a ...